VIVO BIO TECH LTD. Share Price

VIVO BIO TECH LTD. Share Price

NSE: VIVOBIOT
|
Pharmaceuticals
|
S Cap
₹ 17.13
+₹0.14 (0.82%)
1D
Last updated 11 Sep, 2026, 15:50 IST

VIVO BIO TECH LTD. Share Price Today

As of 11 Sep 2026, VIVO BIO TECH LTD. share price is ₹17.13. The stock opened at ₹17.00, compared to its previous close of ₹16.99. During today's trading session, VIVO BIO TECH LTD. share price moved in the range of ₹16.50 to ₹17.37, with an average price of ₹16.94 for the day. Looking at its last 52-week, the stock has touched a low of ₹16.50 and a high of ₹20.94. On the performance front, VIVO BIO TECH LTD. share price has declined by 9.96% over the last six months and is down 9.96% on a year-on-year basis.

₹16.50
0.82% up today
₹17.37
1D LOW
1D HIGH

VIVO BIO TECH LTD. Returns Calculator

Circuit
L
H
₹13.60
₹20.38
52-week
L
H
₹16.50
₹20.94

About VIVO BIO TECH LTD.

VIVO BIO TECH LTD. Share Price
ISIN
INE380K01017
Sector Market Cap
₹ 41.39 Cr

Vivo Bio Tech Limited is an India-based company, which is a comprehensive preclinical clinical research organization (CRO) serving pharmaceutical and biotech firms. It operates in the biotechnology segment. It provides integrated discovery, development & regulatory services to pharmaceutical, agrochemical, industrial chemical, vaccines, nutraceutical & medical device companies. The Company's services include in-Vivo and in-Vitro toxicity studies, pharmacological investigations, pharmacokinetic, toxicokinetic studies, genotoxicity screening and analytical services. It screens and assesses molecules for diverse pharmacological properties. In oncology, it designs syngeneic/xenograft models for anti-cancer agent evaluation. It customizes in-Vivo DMPK studies for rodent and non-rodent models to profile drug candidates. It provides both regulatory and non-regulatory IND-enabling preclinical development services.

VIVO BIO TECH LTD. Financial Highlights

  • Revenue: VIVO BIO TECH LTD. reported revenue of ₹53.77 crore in FY26 vs ₹51.47 crore in FY25. It showed an increase of 4.47% on a yearly basis.
  • Operating Profit: VIVO BIO TECH LTD. reported an operating profit of ₹4.81 crore in FY26 vs ₹8.79 crore in FY25. It showed a decrease of 45.28% on a year-on-year basis.
  • Net Profit: VIVO BIO TECH LTD. reported a net loss of ₹1.71 crore in FY26 vs ₹7.28 crore in FY25. It showed a decrease of 123.49% on a yearly basis.

VIVO BIO TECH LTD. Quarterly Result Highlights

  • VIVO BIO TECH LTD. reported revenue of ₹14.34 crore in Jun 2026, compared with ₹14.23 crore in Mar 2026, representing an increase of 0.77% on a quarter-on-quarter (QoQ) basis.
  • VIVO BIO TECH LTD. reported an operating profit of ₹0.34 crore in Jun 2026, compared with ₹0.25 crore in Mar 2026, representing an increase of 36.00% on a quarter-on-quarter (QoQ) basis.
  • VIVO BIO TECH LTD. reported a profit of ₹0.19 crore in Jun 2026, compared with ₹5.16 crore in Mar 2026, reflecting an increase of 103.68% on a QoQ basis.
  • The earnings per share (EPS) of VIVO BIO TECH LTD. stood at ₹4.76 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
30.62%
FII
0.00%
Other DII
0.00%
Retail and other
69.38%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
37.77
P/E
-13.19
P/B
0.41
ROE
-1.83%
D/E
0.69
ROCE
6.64%
Div. Yield
0.00%
EPS(TTM)
-0.93
Turnover
0.31
EV/EBITDA
5.17
Net Margin
0.00%
Op. Margin
0.00%
ROA
-1.60%
Quick Ratio
0.00
Curr. Ratio
3.03
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Vivo Bio Tech has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Vivo Bio Tech appears overvalued compared to its peers
Step 4 of 5
Earnings
Good
Vivo Bio Tech revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,47,236.0036.915.3513.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,49,673.0085.3614.9015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,87,460.0086.9522.2925.49%1.6913.85%222.760.69%0.4958.70
Zydus Lifesciences1,11,521.0024.284.1118.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,484.0033.223.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,04,604.0095.9419.7416.77%0.4016.14%97.200.10%0.6713.72
Aurobindo Pharma96,030.6025.882.539.25%0.1911.76%394.820.24%0.3841.58
Lupin94,882.7017.094.2323.76%0.0424.88%659.000.87%0.57129.18
Dr. Reddy's Laboratories95,220.3029.912.5011.07%0.1812.54%377.950.70%0.4138.68
Mankind Pharma92,769.9044.875.6911.74%0.3413.13%396.980.04%0.4449.37

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

VIVO BIO TECH LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹46.67₹45.45₹52.23₹51.39
Other Income₹4.80₹0.04₹0.04₹0.10
Total Revenue₹51.48₹45.49₹52.27₹51.49
Total Expenses₹42.68₹41.43₹47.65₹47.02
Profit Before Tax₹8.79₹4.06₹4.62₹4.47
Tax₹1.51₹1.53₹1.97₹2.27
Profit After Tax₹7.28₹2.53₹2.65₹2.20
EPS - Basic₹4.76₹1.70₹1.78₹1.56
EPS - Diluted₹4.76₹1.51₹1.78₹1.56

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹8.79₹4.06₹4.62₹4.47
Income before WC changes₹20.70₹21.13₹21.54₹15.91
Change in Assets₹5.23-₹15.43-₹6.15₹1.25
Change in Liabilities-₹10.56₹12.88₹2.79₹2.93
Change in WC-₹5.32-₹2.55-₹3.37₹4.18
Cash flow from Operations₹11.83₹15.52₹14.83₹16.64
Cash flow from Investing-₹15.84-₹7.95-₹4.00-₹51.11
Cash flow from Financing₹3.90-₹7.56-₹11.18₹35.02
Total Cash Flow-₹0.11₹0.01-₹0.34₹0.55
Cash (Start of the year)₹1.39₹1.37₹1.71₹1.17
Cash (End of the year)₹1.28₹1.39₹1.37₹1.71

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹101.29₹89.90₹91.24₹96.45
Current Assets₹41.94₹47.23₹31.79₹26.03
Total Assets₹143.23₹137.13₹123.03₹122.49
Current Liabilities₹27.84₹37.91₹24.97₹23.18
Net Current Asset₹14.10₹9.32₹6.82₹2.85
Non-Current Liabilities₹37.49₹44.82₹46.19₹52.18
Equity Capital₹77.90₹54.40₹51.87₹47.13
Total Equity & Liabilities₹143.23₹137.13₹123.03₹122.49

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹46.67₹44.88₹51.62₹51.39
Other Income₹4.80₹0.04₹0.04₹0.09
Total Revenue₹51.48₹44.92₹51.66₹51.48
Total Expenses₹42.40₹40.86₹47.05₹47.01
Profit Before Tax₹9.08₹4.05₹4.61₹4.47
Tax₹1.51₹1.53₹1.97₹2.27
Profit After Tax₹7.57₹2.52₹2.63₹2.20
EPS - Basic₹4.95₹1.69₹1.77₹1.56
EPS - Diluted₹4.95₹1.51₹1.77₹1.56

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹9.08₹4.05₹4.61₹4.47
Income before WC changes₹20.99₹21.12₹21.52₹15.91
Change in Assets₹4.85-₹15.01-₹6.25₹1.05
Change in Liabilities-₹9.89₹12.78₹2.79₹2.93
Change in WC-₹5.04-₹2.24-₹3.46₹3.98
Cash flow from Operations₹11.83₹15.83₹14.73₹16.43
Cash flow from Investing-₹15.84-₹7.95-₹4.00-₹51.11
Cash flow from Financing₹3.90-₹7.56-₹11.20₹35.04
Total Cash Flow-₹0.11₹0.32-₹0.47₹0.37
Cash (Start of the year)₹1.32₹0.99₹1.47₹1.10
Cash (End of the year)₹1.21₹1.32₹0.99₹1.47

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹97.97₹86.58₹87.92₹93.12
Current Assets₹43.31₹48.22₹32.88₹27.18
Total Assets₹141.29₹134.80₹120.81₹120.30
Current Liabilities₹27.84₹37.81₹24.97₹23.18
Net Current Asset₹15.48₹10.41₹7.92₹4.00
Non-Current Liabilities₹35.26₹42.59₹43.96₹49.97
Equity Capital₹78.19₹54.40₹51.87₹47.14
Total Equity & Liabilities₹141.29₹134.80₹120.81₹120.30
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
17.13
108
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 108
Buy orders: 0%
Sell orders: 100%
Bearish
2
Neutral
2
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
37.77
Neutral
ATR (14)
1.16
Neutral
STOCH(9,6)
7.43
Bullish
ADX(9)
41.86
Bearish
ROC(12)
-9.87
Bearish
WillR(14)
-92.57
Bullish
Period
Simple value
Exponential vaue
5D
18.49
18.17
10D
18.43
18.38
20D
18.69
0
50D
18.69
0
100D
18.69
0
Volume trend — traded volume by day
11 Sep0L
10 Sep1L
9 Sep0L
8 Sep0L
7 Sep0L
4 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
VIVO BIO TECH LTD. Share Price
VIVO BIO TECH LTD.
Pharmaceuticals
Add Stock
Add Another

VIVO BIO TECH LTD. Share Price FAQs

VIVO BIO TECH LTD. share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837